K C Pharmaceuticals Inc

International Medication Systems, based in South El Monte, Calif., is a federally registered and internationally licensed manufacturer of sterile injectable pharmaceuticals that supplies to both domestic and international markets. The sterile injectables are used with a wide variety of the company s delivery systems, including prefilled syringes and vials. It also manufactures and markets a number of sterile plastic fluid transfer devices. The company maintains an excellent regulatory compliance record and has experience in dealing with Federal, international and local regulatory agencies. Its facilities are registered and inspected regularly by the United States Food and Drug Administration, the Medicines Control Agency of the United Kingdom, the United States Drug Enforcement Agency and the California State Food and Drug Board.

Headquartered in Orange, Calif., NuCare Pharmaceuticals provides prepackaged pharmaceutical products for physician offices, hospitals and pharmacies. It is licensed by Food and Drug Administration. The company operates an online allergy center that offers information about identifying and treating several allergic conditions. NuCare Pharmaceuticals additionally publishes articles and researches in areas of health care. It provides a range of tablets, capsules, syringes and injections. The company offers medical supplies for cough and cold, cardiac problems, hormonal disorders, central nervous system and analgesics. NuCare Pharmaceuticals features emergency rooms and urgent care centers.

Stason Pharmaceuticals is a US-based pharmaceutical company headquartered in Irvine, California, specializing in the development of partnerships and drugs within oncology, renal, and orphan indications. With its contract service divisions, MPhS and Western PharmSci, the company provides comprehensive contract packaging, analytical testing, and CDMO services to drug-development companies, supporting both clinical trial materials and commercial production of high-potency products. Since entering the US generic market in 1994, Stason has established a diverse portfolio and a global network of distributors. The company combines its advanced manufacturing capabilities, including high containment facilities, with strategic alliances across the US, Canada, Europe, and Asia to foster innovation and ensure compliance with industry standards. Generated from the website